Saltigo at 23rd Interphex/Pharma-i Japan, Tokyo Big Site East Hall, booth 40-39
Saltigo presents broad range of technologies and services for Japanese market, from pre-clinical to commercial production.
Tokyo - Custom manufacturing specialist Saltigo GmbH will present its comprehensive portfolio of technologies and services at the 23rd Interphex/Pharma-i Japan in Tokyo from June 30 to July 2, 2010. On display from this wholly owned subsidiary of specialty chemicals group LANXESS will be the company´s broad range of technologies and services, from pilot production in the early stages of pharmaceutical development up to large-scale production of active pharmaceutical ingredients.
As Asia´s largest pharmaceutical industry gathering, Interphex Japan attracts key decision makers from the pharmaceutical industry, making the Pharma-i pharmaceutical ingredients section an ideal platform for Saltigo. The custom manufacturer already enjoys a good level of business activity in Japan across all market sectors, especially crop protection, pharmaceuticals, specialty chemicals, and others serving the life science industries. Japan is one of the company`s most important Asian markets.
Pharma-i Japan will highlight Saltigo´s capabilities for supporting development-stage projects -through specialized services including process development, regulatory support, analytical development, and crystal refinement, The company provides solutions for all stages of projects for active pharmaceutical ingredients and intermediates, covering
- small-lot synthesis of pre-clinical work and process improvements
- manufacturing scale up expertise necessary to support progression
- all clinical phases and commercialization with strong focus on product quality and optimal cost of goods, and
- the launch of new products.
Show visitors will thus be able to see that Saltigo has strong systems in place to offer complete support throughout the entire lifecycle of pharmaceutical projects, from pre-
clinical work to commercial production at its plants in Germany.
Japan is well-known for its commitment to new technologies and innovative products. This coupled with customers´ extremely stringent demands for higher tier performance is perfectly in line with Saltigo´s strategy to expand service offerings in the country. As Saltigo´s pharmaceutical business activities continue to expand, the company is committed to further develop this market sector with strategic investments to even better serve its existing and developing customer base.
